Evoke Pharma, Inc. (EVOK)
NASDAQ: EVOK · Real-Time Price · USD
2.590
+0.080 (3.19%)
At close: Apr 2, 2025, 4:00 PM
2.569
-0.021 (-0.81%)
After-hours: Apr 2, 2025, 6:00 PM EDT

Evoke Pharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
59491868
Upgrade
Market Cap Growth
160.15%160.15%-60.81%-50.12%-73.62%73.44%
Upgrade
Enterprise Value
-33321264
Upgrade
Last Close Price
2.514.4212.6032.1679.20371.52
Upgrade
PS Ratio
0.470.890.683.5711.102957.72
Upgrade
PB Ratio
0.721.30-1.362.195.05-21.18
Upgrade
P/TBV Ratio
1.301.30-2.195.05-
Upgrade
EV/Sales Ratio
0.270.270.490.707.342777.86
Upgrade
Debt / Equity Ratio
0.730.73-1.941.261.41-1.63
Upgrade
Asset Turnover
0.830.830.550.220.160.00
Upgrade
Inventory Turnover
0.770.770.521.561.56-
Upgrade
Quick Ratio
1.541.540.566.336.721.07
Upgrade
Current Ratio
1.661.660.717.097.511.23
Upgrade
Return on Equity (ROE)
-240.09%-240.09%-1035.44%-215.30%-5015.39%-2256.53%
Upgrade
Return on Assets (ROA)
-26.46%-26.46%-49.09%-43.40%-50.93%-103.03%
Upgrade
Return on Capital (ROIC)
-44.50%-44.50%-79.84%-54.74%-96.14%-248.98%
Upgrade
Earnings Yield
-103.02%-58.59%-221.93%-91.79%-47.54%-19.32%
Upgrade
Buyback Yield / Dilution
-583.90%-583.90%-6.33%-17.21%-26.26%-14.34%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q